About
Profile
BioMarin is a world leader in developing and commercializing innovative biopharmaceuticals for rare diseases driven by genetic causes At BioMarin, we focus on developing first-in-class and best-in-class therapeutics that provide meaningful advances to
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
BMRN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.02, revenue of $581.3M misses by $26.46M
- BioMarin appoints Alexander Hardy as president and chief executive officer
- BioMarin Pharmaceutical Q3 2023 Earnings Preview
- Bernstein upgrades BioMarin to market perform, citing valuation
- FDA approves use of BioMarin drug Voxzogo in children under 5
- BioMarin a market perform at Raymond James due to growth concerns
- BioMarin Pharmaceutical Non-GAAP EPS of $0.54 beats by $0.07, revenue of $595.3M in-line
- BioMarin Pharmaceutical Q2 2023 Earnings Preview
- BioMarin upgraded at BMO after FDA nod for hemophilia A therapy
- BioMarin granted FDA nod for hemophilia A gene therapy
- Eli Lilly, Humana among best health care names in defensive environment - BofA
- BioMarin Pharmaceutical Non-GAAP EPS of $0.60 beats by $0.20, revenue of $596.4M beats by $26.01M
- BioMarin Pharmaceutical Q1 2023 Earnings Preview
- What is behind biotech M&A resurgence?
- FDA to back accelerated approval pathway for gene therapies
- BioMarin seeks FDA nod to expand use of its Voxzogo treatment in children under five
- BioMarin's Roctavian gets FDA action date extended to end of June
- BridgeBio soars 55% after Phase 2 data for achondroplasia candidate
- BioMarin Pharmaceutical GAAP EPS of $0.00 beats by $0.07, revenue of $537.5M misses by $0.74M
- BioMarin Pharmaceutical Q4 2022 Earnings Preview
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Dec 4 | 53.85 | 54.33 |
54.66
|
53.64
|
1.4M | -0.85% | |||
| Dec 3 | 54.31 | 53.52 |
54.4
|
53.03
|
2.2M | 0.78% | |||
| Dec 2 | 53.89 | 55.22 |
55.34
|
53.88
|
2.1M | -2.07% | |||
| Dec 1 | 55.03 | 55.5 |
56.09
|
54.95
|
2.3M | -1.61% | |||
| Nov 28 | 55.93 | 55.77 |
56.05
|
55.03
|
1.2M | 0.74% | |||
| Nov 26 | 55.52 | 56.26 |
56.39
|
54.51
|
3.6M | -1.37% | |||
| Nov 25 | 56.29 | 55.6 |
56.45
|
55.35
|
2.5M | 1.42% | |||
| Nov 24 | 55.5 | 54.22 |
56.13
|
53.93
|
17.4M | 1.48% | |||
| Nov 21 | 54.69 | 52.72 |
54.76
|
52.51
|
3.0M | 4.21% | |||
| Nov 20 | 52.48 | 52.62 |
53.72
|
52.36
|
2.1M | -0.15% | |||
| Nov 19 | 52.56 | 53.88 |
53.88
|
51.99
|
2.1M | -2.95% | |||
| Nov 18 | 54.16 | 54.32 |
54.52
|
52.91
|
2.0M | -0.55% | |||
| Nov 17 | 54.46 | 54.13 |
55.24
|
54
|
2.2M | -0.49% | |||
| Nov 14 | 54.73 | 54.18 |
55.29
|
53.67
|
2.0M | 0.94% | |||
| Nov 13 | 54.22 | 55 |
55.34
|
54.16
|
2.3M | -1.99% | |||
| Nov 12 | 55.32 | 54.94 |
55.33
|
54.31
|
2.1M | 0.71% | |||
| Nov 11 | 54.93 | 53 |
54.97
|
52.85
|
2.3M | 4.29% | |||
| Nov 10 | 52.67 | 51.94 |
52.8
|
51.81
|
2.1M | 2.35% | |||
| Nov 7 | 51.46 | 51.9 |
51.9
|
50.76
|
3.1M | -0.73% | |||
| Nov 6 | 51.84 | 52.03 |
52.68
|
51.42
|
3.0M | -1.82% | |||
| Nov 5 | 52.8 | 52.17 |
53.5
|
51.86
|
2.1M | 0.53% | |||
| Nov 4 | 52.52 | 52.56 |
52.76
|
51.8
|
2.0M | -0.62% | |||
| Nov 3 | 52.85 | 53.03 |
54.25
|
52.06
|
2.7M | -1.34% | |||
| Oct 31 | 53.57 | 51.33 |
53.62
|
51
|
3.3M | 3.20% | |||
| Oct 30 | 51.91 | 51.86 |
52.49
|
51.1
|
2.7M | 0.10% | |||
| Oct 29 | 51.86 | 53.46 |
54.75
|
51.74
|
4.8M | -3.05% | |||
| Oct 28 | 53.49 | 53.4 |
56.8
|
53.27
|
6.5M | 1.56% | |||
| Oct 27 | 52.67 | 54.98 |
55.84
|
52.26
|
5.5M | -3.32% | |||
| Oct 24 | 54.48 | 54.49 |
55.03
|
54.19
|
2.1M | -0.13% | |||
| Oct 23 | 54.55 | 53.49 |
54.61
|
53.14
|
2.3M | 2.21% | |||
| Oct 22 | 53.37 | 53.81 |
54.41
|
53.22
|
2.5M | -0.82% | |||
| Oct 21 | 53.81 | 53.08 |
53.98
|
52.62
|
1.9M | 1.39% | |||
| Oct 20 | 53.07 | 53.54 |
53.54
|
52.14
|
2.0M | -0.41% | |||
| Oct 17 | 53.29 | 52.6 |
53.49
|
52.58
|
1.8M | 0.64% | |||
| Oct 16 | 52.95 | 53.09 |
53.96
|
52.38
|
2.2M | -0.26% | |||
| Oct 15 | 53.09 | 52.34 |
53.76
|
52.19
|
1.9M | 1.18% | |||
| Oct 14 | 52.47 | 51.78 |
52.81
|
51.56
|
2.5M | 0.04% | |||
| Oct 13 | 52.45 | 52.58 |
52.9
|
51.85
|
2.3M | 0.25% | |||
| Oct 10 | 52.32 | 54.16 |
54.25
|
51.78
|
3.0M | -2.84% | |||
| Oct 9 | 53.85 | 55.39 |
55.39
|
53.74
|
3.4M | -1.54% | |||
| Oct 8 | 54.69 | 54.57 |
55.2
|
54.18
|
1.3M | -0.02% | |||
| Oct 7 | 54.7 | 55.92 |
56.26
|
54.58
|
1.6M | -1.64% | |||
| Oct 6 | 55.61 | 56.06 |
56.06
|
55.28
|
1.8M | 0.32% | |||
| Oct 3 | 55.43 | 55.5 |
56
|
55.01
|
2.4M | -0.25% | |||
| Oct 2 | 55.57 | 54.9 |
55.99
|
54.58
|
2.1M | 1.29% | |||
| Oct 1 | 54.86 | 54.29 |
55.75
|
54.26
|
2.9M | 1.29% | |||
| Sep 30 | 54.16 | 53.96 |
54.42
|
53.19
|
1.8M | 0.26% | |||
| Sep 29 | 54.02 | 53.76 |
54.38
|
53.5
|
1.6M | 0.32% | |||
| Sep 26 | 53.85 | 53 |
53.97
|
52.65
|
1.8M | 2.34% | |||
| Sep 25 | 52.62 | 54.18 |
54.5
|
52.47
|
2.7M | -2.14% | |||
| Sep 24 | 53.77 | 53.2 |
53.87
|
53
|
1.4M | 0.67% | |||
| Sep 23 | 53.41 | 54.09 |
54.12
|
52.91
|
2.0M | -0.98% | |||
| Sep 22 | 53.94 | 54.35 |
54.7
|
53.81
|
2.0M | -0.77% | |||
| Sep 19 | 54.36 | 55.52 |
55.52
|
54.21
|
5.0M | -1.41% | |||
| Sep 18 | 55.14 | 54.57 |
55.22
|
54.43
|
1.5M | 1.42% | |||
| Sep 17 | 54.37 | 53.85 |
55.18
|
53.62
|
2.7M | 0.80% | |||
| Sep 16 | 53.94 | 53.2 |
54.42
|
53.15
|
2.3M | 1.51% | |||
| Sep 15 | 53.14 | 54.25 |
54.39
|
52.94
|
1.8M | -1.76% | |||
| Sep 12 | 54.09 | 55.65 |
56.07
|
54.05
|
1.9M | -3.26% | |||
| Sep 11 | 55.91 | 54.46 |
55.94
|
54.2
|
2.0M | 0% | |||